![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
York Pharma | LSE:YRK | London | Ordinary Share | GB00B00QHC86 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMYRK RNS Number : 0687U York Pharma plc 17 June 2009 +----------------------------------------------------------------------------+ | TR-1:NOTIFICATION OF MAJOR INTERESTS IN SHARES | +----------------------------------------------------------------------------+ +--------------------------------------+----------------+----------------+------------+ | 1. Identity of the issuer or the | York Pharma plc | | underlying issuer | | | of existing shares to which voting | | | rights are | | | attached: | | +-------------------------------------------------------+-----------------------------+ | 2. Reason for the notification (please tick the appropriate box or boxes): | | | +-------------------------------------------------------------------------------------+ | An acquisition or disposal of voting rights | X | +------------------------------------------------------------------------+------------+ | An acquisition or disposal of qualifying financial instruments | | | which may result in the acquisition of shares already issued to | | | which voting rights are attached | | +------------------------------------------------------------------------+------------+ | An acquisition or disposal of instruments with similar economic | | | effect to qualifying financial instruments | | +------------------------------------------------------------------------+------------+ | An event changing the breakdown of voting rights | | +------------------------------------------------------------------------+------------+ | Other (please specify): | | +------------------------------------------------------------------------+------------+ | 3. Full name of person(s) | Lanstead Partners Limited | | subject to the | | | notification obligation: | | +--------------------------------------+----------------------------------------------+ | 4. Full name of | KAS Nominees Limited | | shareholder(s) | | | (if different from 3.): | | +--------------------------------------+----------------------------------------------+ | 5. Date of the transaction and date | 15/06/2009 | | on | | | which the threshold is crossed or | | | reached: | | +--------------------------------------+----------------------------------------------+ | 6. Date on which issuer | 15/06/2009 | | notified: | | +--------------------------------------+----------------------------------------------+ | 7. Threshold(s) that is/are | 3% threshold | | crossed or | | | reached: | | +--------------------------------------+----------------+----------------+------------+ +-----------+---------+--------------+-----------------+--------------+--------------+----------------+--------------+----------------+ | 8. Notified details: | +--------------------------------------------------------------------------------------------------------------------+ | A: Voting rights attached to shares | +-------------------------------------------------------------------------------------------------------------------------------------+ | Class/type | Situation | Resulting situation after the | | of shares | previous | triggering transaction | | if | to the | | | possible | triggering | | | using the | transaction | | | ISIN CODE | | | | | | | + +--------------------------------+------------------------------------------------------------------------------+ | | Number | Number | Number | Number of | % of | | | of | | of | voting rights | voting | | | Shares | of | shares | | rights | | | | Voting | | | | | | | Rights | | | | + + + +--------------+-------------------------------+-------------------------------+ | | | | Direct | Direct | Indirect | Direct | Indirect | +---------------------+--------------+-----------------+--------------+--------------+----------------+--------------+----------------+ | GB00B00QH86 | 2,411,611 | 2,411,611 | | 273,611 | 0 | | 0 | | (Ordinary) | | | 273,611 | | | 0.445% | | +-----------+---------+--------------+-----------------+--------------+--------------+----------------+--------------+----------------+ +------------------+------------------+---------------------+----------------------------+-----------------+ | B: Qualifying Financial Instruments | +----------------------------------------------------------------------------------------------------------+ | Resulting situation after the triggering transaction | +----------------------------------------------------------------------------------------------------------+ | Type of | Expiration | Exercise/ | Number of voting | % | | financial | date | Conversion | rights that may be | of | | instrument | | Period | acquired if the | voting | | | | | instrument is | rights | | | | | exercised/converted | | +------------------+------------------+---------------------+----------------------------+-----------------+ | | | | | | +------------------+------------------+---------------------+----------------------------+-----------------+ +------------------+----------------+---------------------+-------------------+--------------------+---------------+--------+ | C: Financial Instruments with similar economic effect to Qualifying | | Financial Instruments | +---------------------------------------------------------------------------------------------------------------------------+ | Resulting situation after the triggering transaction | +---------------------------------------------------------------------------------------------------------------------------+ | Type of | Exercise | Expiration | Exercise/ | Number of | % | | financial | price | date | Conversion | voting | of | | instrument | | | period | rights | voting | | | | | | instrument | rights | | | | | | refers to | | +------------------+----------------+---------------------+-------------------+--------------------+------------------------+ | | | | | | Nominal | Delta | + + + + + +---------------+--------+ | | | | | | | | +------------------+----------------+---------------------+-------------------+--------------------+---------------+--------+ +--------------------------------------+---------------------------------------+ | Total (A+B+C) | +------------------------------------------------------------------------------+ | Number of voting rights | % of voting rights | +--------------------------------------+---------------------------------------+ | 273,611 | 0.445% | +--------------------------------------+---------------------------------------+ | 9. Chain of controlled undertakings through which the voting rights | | and/or the financial instruments are effectively held, if | | applicable: | +------------------------------------------------------------------------------+ | | +--------------------------------------+---------------------------------------+ +---------------------------------------+------------------------------------+ | Proxy Voting: | | | +----------------------------------------------------------------------------+ | 10. | | | Name of | | | the proxy | | | holder: | | +---------------------------------------+------------------------------------+ | 11. | | | Number of | | | voting | | | rights | | | proxy | | | holder | | | will cease | | | to hold: | | +---------------------------------------+------------------------------------+ | 12. | | | Date on | | | which | | | proxy | | | holder | | | will cease | | | to | | | hold | | | voting | | | rights: | | +---------------------------------------+------------------------------------+ +------------------------------------------+------------------------------------+ | 13. | | | Additional | | | information: | | +------------------------------------------+------------------------------------+ | 14. | Sue Keast | | Contact | | | name: | | +------------------------------------------+------------------------------------+ | 15. | 07771 888536 | | Contact | | | telephone | | | number: | | +------------------------------------------+------------------------------------+ This information is provided by RNS The company news service from the London Stock Exchange END HOLBSGDLDXBGGCR
1 Year York Pharma Chart |
1 Month York Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions